Blockchain for PHARMA Scientists & Engineers
  • What is Blockchain BioPharma?
    • Blockchain BioPharma: R&D Origins
      • Harvard Business Review: Why Big Pharma Is Betting on Blockchain
    • 2022 DEV OPS ROADMAP
    • WEDNESDAY, MARCH 16,2022 SPRINT 0: DEMO VIDEO
    • PHARMA INDUSTRY SOLUTIONS: The 80/20 Non-Profit Pharma Company
    • Our Calling for a Pharmaceutical Coalition
    • BLOCKCHAIN BIOPHARMA: INVESTMENT GOALS AND CRITERIA DATA
    • $20(M-USD) Is The Important Number - As of Now We Have 200 Million ERC & BEP PHARMA Tokens.
    • DAO Mission & Vison
      • Where Will Pharmaceutical eNFT's Come From?
    • Information Architecture Diagram
      • WARNING! ALT-COINS GLOBALLY TARGETED - NEED FOR DEVSECOPS
    • Blockchain BioPharma GAP Analysis
    • Blockchain BioPharma Tokenomics
      • PROPOSED GLOBAL CENTRAL BANK CBDC INTEGRATIONS
      • INTEGRATION POINTS FOR SWIFT & CBDC's
    • BANKING-GRADE SECURITY: SWIFT CODE INTEGRATION
    • Sales & Revenue Model
      • PRODUCT: Quantum SSO
      • PRODUCT: Metaverse Software Apps
      • PRODUCT: eNFT Marketplace for Medicines (Polygon)
        • TYPES OF ENTERPRISE PHARMA eNFT’s:
      • PRODUCT: Metaverse of PHARMA - Introducing CloudLab (VR/AR)
      • SERVICE: Metaverse Development MSP
        • Blockchain BioPharma: MSP Services Rate Card
      • SERVICE: Private-Label IP Monetization (HyperLedger)
      • SERVICE: ENTERPRISE BLOCKCHAIN SMART CONTRACT GAS-FEES
    • What is the Pharmaceutical Token (Ticker: PHARMA)?
      • Are PHARMA Tokens Regulated?
      • Legal Position on the Pharmaceutical Token
      • Using Ethereum Blockchain for Pharmacogenomics Smart Contracts
    • Where Can You Download The Blockchain BioPharma Desktop Applications?
    • What Industries Do We Target?
    • Are PHARMA Tokens on the Cryptocurrency Exchanges?
    • Who Uses The Blockchain BioPharma Application?
    • Does Blockchain BioPharma Loan Money to Drug Developers?
    • Desktop Software Demo
    • Enterprise Pharma eNFT Example
    • Artificial Intelligence & Machine Learning
    • STATE OF THE METAVERSE UNION - Metaverse Market Research
    • Q2 - 2022: Crowdsale
    • Smart Contract Types
    • Competitive Landscape
      • AGILE: Our Competitive Advantage
  • The Competition Justifies our Business Model
    • COMPETITOR #1: Molecule.to
    • COMPETITOR #2: Pharmalyse Finance
  • Get in Touch With Our Community
  • 100% Regulatory and Compliance Transparency
    • Crypto Accounting 101: Price Water House Coopers Regulatory Compliance Opinion
Powered by GitBook
On this page

Was this helpful?

  1. What is Blockchain BioPharma?

Q2 - 2022: Crowdsale

-> INVESTORS BE WARNED! WE DO NOT HAVE A BALANCE SHEET, INCOME STATEMENT, OR CASH FLOW STATEMENT. THE REASON WHY IS THAT NO ONE HAS EVER LAUNCHED A METAVERSE BUSINESS IN THE PHARMACEUTICAL SECTOR<-

PreviousSTATE OF THE METAVERSE UNION - Metaverse Market ResearchNextSmart Contract Types

Last updated 3 years ago

Was this helpful?

With Pharmaceutical R&D Investments down in Q1 2022 due to the strain of COVID, as well as its profit opportunity to the PHARMA industry: We believe our Product Thesis proposes the best way to "course correct" these investment numbers.

DISCLAIMER: As of this date, we seek only Accredited Investors and partners such as Fortune 1,000 Companies, governments, universities, and globally competitive existing pharmaceutical companies, all of whom have the Fractionalized Intellectual Property (IP) NFT's source patents assigned to them. We need to begin to think in genetics, pharmacogenetics, and in terms of compounds and molecules. PHARMA Token investments are considered a High Risk Investment .

Additionally, this risk lies in the highly-controversial (from a legal perspective) Blockchain Industry, where Regulations are institutionally adopted, but Regulatory and Compliance constantly lie in a "Grey Area" that constantly changes as a moving target, as per disclosure, which the reader should be aware of. PHARMA Token is classified as a , and , and a by US Regulatory and Compliance Agencies, all of whom we contacted as part of our US Government lobbying effort throughout the .

COVID was politicized, disorganized, and in #DataScience Chaos. We iterated the approach to get #BioTech right.

This project's pharma, blockchain, NFT, and all other initial, Non-Profit R&D was done as part of a graduate school thesis which stemmed from a necessary on the side of #TransparentData in the Pharmaceutical, Life Science, and Nutrition Science industries.

#COVID19Response
#derivative
#ALTCoin
#UtilityToken
#COVID19Pandemic
THE IMPLICATIONS ARE HUGE: Our new, never before been done, collaborative platform for the development of new medicines, would change the course of history for medicine: and especially for the poor and disenfranchised of the world, such as those who suffered from #Coronavirus Vaccine-inequity.